Charles Schwab’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $49M | Buy |
|
|||||
|
2025
Q2 | $29.8M | Buy |
|
|||||
|
2025
Q1 | $30.2M | Sell |
|
|||||
|
2024
Q4 | $29.9M | Buy |
|
|||||
|
2024
Q3 | $45.5M | Buy |
|
|||||
|
2024
Q2 | $32.4M | Buy |
|
|||||
|
2024
Q1 | $14M | Buy |
|
|||||
|
2023
Q4 | $4.94M | Buy |
|
|||||
|
2023
Q3 | $3.29M | Sell |
|
|||||
|
2023
Q2 | $5.9M | Buy |
|
|||||
|
2023
Q1 | $7.5M | Buy |
|
|||||
|
2022
Q4 | $10.3M | Buy |
|
|||||
|
2022
Q3 | $6.16M | Buy |
|
|||||
|
2022
Q2 | $4.9M | Buy |
|
|||||
|
2022
Q1 | $5.54M | Buy |
|
|||||
|
2021
Q4 | $6.93M | Buy |
|
|||||
|
2021
Q3 | $6.98M | Buy |
|
|||||
|
2021
Q2 | $3.53M | Sell |
|
|||||
|
2021
Q1 | $3.13M | Buy |
|
|||||
|
2020
Q4 | $2.8M | Buy |
|
|||||
|
2020
Q3 | $3.04M | Buy |
|